|
|
|
Cell Therapy Manufacturing & Gene Therapy Congress |
 |
|
4-6 December 2018
RAI, Amsterdam
Bringing together 300+ leaders and key influencers from
pharma and biotech companies on 4 - 6 December 2018 in Amsterdam, Cell Therapy
Manufacturing & Gene Therapy will provide you with the latest advice for
transforming innovative research to prosperous cell & gene therapy
manufacturing.
Gain regulatory approval. Maximise ROI. Ensure a
stringent vein-to-vein supply chain.
Discover everything you need in one place. Move between 4
streams jam packed with topical talks and industry case studies. PLUS it’s the
perfect opportunity to meet with colleagues for an unrivalled on-site
experience.
Contact details of organisers:
Registrations: LS.Registrations@knect365.com
Agenda/Speaker Inquiries: Sarah Lintern - Sarah.Lintern@knect365.com
Marketing, Media and Website Inquiries: Shahana Chowdhury - Shahana.Chowdhury@knect365.com Exhibition
& Sponsorship Inquiries: Luke Pickering – Luke.Pickering@knect365.com |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
CPhI & P-MEC India 2018
12-14 December 2018, India Expo Mart, New Delhi, India
CPhI & P-MEC India (December 12-14, 2018) – organised by UBM (part
of Informa PLC) – announces that the 12th edition of Asia’s
largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new
venue will see the exhibition now hosted in a single venue, bringing it closer
to the Indian regulatory and legislative capital. New Delhi is also the
country’s main international transport hub and will encourage an increased
international attendance. In total, more than 50,000 people from 122 countries
are expected, along with nearly 1,500 exhibitors.
More info >> |
|
 |
White Papers |
 |
|
Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test
Wickham Laboratories Limited
Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >> |
|
 |
News and Press Releases |
 |
Charles River Laboratories Continues Commitment to Oncology Drug Discovery
Charles River Laboratories International, Inc. (NYSE: CRL) today announced new additions to the Tumor Model Compendium. Charles River’s Compendium provides access to a comprehensive collection of well-established tumor models for early-stage oncology research.
More info >> |
|
|
